Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Find out how CRISPR genome editing technologies are shaping the future of drug development; we ask experts about the hype versus reality. Also in this issue, patient centricity at Boehringer Ingelheim, real-world data, and why the pharma industry shouldn’t ignore the need for dengue treatments. Academics explain how they have converted plastic waste into pharmaceutical APIs, members of our Power List explore the challenges facing cell and gene therapy, and we invite you to learn more about the importance of crystallization for API manufacturing.